Literature DB >> 16246449

Resistance to adefovir: a new challenge in the treatment of chronic hepatitis B.

Patrick Marcellin, Tarik Asselah.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246449     DOI: 10.1016/j.jhep.2005.09.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

1.  Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present.

Authors:  Daniel J Tenney; Ronald E Rose; Carl J Baldick; Steven M Levine; Kevin A Pokornowski; Ann W Walsh; Jie Fang; Cheng-Fang Yu; Sharon Zhang; Charles E Mazzucco; Betsy Eggers; Mayla Hsu; Mary Jane Plym; Patricia Poundstone; Joanna Yang; Richard J Colonno
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

Review 2.  Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-naïve Asian patients with chronic hepatitis B: a meta-analysis.

Authors:  Pan Zhao; Weiwei Liu; Jun Zhao; Qun Guan
Journal:  Virol J       Date:  2011-02-22       Impact factor: 4.099

3.  Antiviral treatment of chronic hepatitis B virus (HBV) infections.

Authors:  Erik De Clercq; Geoffrey Férir; Suzanne Kaptein; Johan Neyts
Journal:  Viruses       Date:  2010-05-31       Impact factor: 5.818

4.  Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients.

Authors:  Mostafa Mahabadi; Mehdi Norouzi; Seyed Moayyed Alavian; Katayoon Samimirad; Talat Mokhtari Azad; Esmaeil Saberfar; Mahmood Mahmoodi; Fatemeh Ramezani; Hadi Karimzadeh; Reza Malekzadeh; Ghodrat Montazeri; Azim Nejatizadeh; Masood Ziaee; Farshid Abedi; Behrooz Ataei; Majid Yaran; Babak Sayad; Mohammad Hossein Somi; Gholamreza Sarizadeh; Ismaeil Sanei-Moghaddam; Fariborz Mansour-Ghanaei; Houshang Rafatpanah; Mohammad Amin Pourhosseingholi; Hossain Keyvani; Ebrahim Kalantari; Mehdi Saberifiroozi; Mohammad Ali Judaki; Shiva Ghamari; Maryam Daram; Zeinab Fazeli; Zahra Goodarzi; Abolfazl Khedive; Abdolvahab Moradi; Seyed Mohamad Jazayeri
Journal:  Hepat Mon       Date:  2013-01-20       Impact factor: 0.660

5.  Mutational analysis of reverse transcriptase and surface proteins of patients with partial virological response during mono and combination antiviral therapies in genotype D chronic hepatitis B.

Authors:  Mostafa Mahabadi; Seyed Moayed Alavian; Mehdi Norouzi; Hossein Keyvani; Mahmood Mahmoudi; Seyed Mohammad Jazayeri
Journal:  Electron Physician       Date:  2016-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.